燕陈

BD Associate Director @ Hubei Jumpcan Pharmaceutical Co Ltd

About

With nearly fifteen years of extensive experience in business development, I have specialized in product evaluation, business expansion, and strategic alliance management within the pharmaceutical industry. I have held positions at renowned companies such as Pierre Fabre Pharmaceuticals (China), Yangtze River Pharmaceutical Group, and Exeltis China and have successfully led and participated in the full - process introduction and cooperation of numerous innovative drugs and antibody - based projects in the fields of oncology, autoimmune diseases, neurology, chronic conditions, and dermatology. I possess outstanding capabilities in project research, evaluation, negotiation, and contract management, and is proficient in expanding high - quality pipeline products for companies through diverse cooperation models such as patent licensing and joint development, thereby driving business growth.

Country

China

City

Shanghai

Industry

Biotechnology

Skill

新药开发, 估值, 业务拓展策略, 市场准入策略, 国际业务开发, 项目管理, 知识产权建设, 战略规划

Experience

BD Associate Director

Hubei Jumpcan Pharmaceutical Co Ltd

2026-5 - Present · 5 mos

上海市, 中国

Support global pharma companies access the China market through CSO, in-licensing, and divestiture partnerships, leveraging Jumpcan's 6,000+ hospital network and broad-market reach in Respiratory, Immunology, and Pediatrics.

Senior BD Manager

Pierre Fabre Laboratories

2022-8 - 2026-5 · 3 yrs 10 mos

上海市, 中国

Built the China BD function from ground zero, shaping and executing the full BD strategy for the China market. Led multiple cross-border transactions covering in-licensing opportunities across Oncology, Dermatology, and Rare Diseases — from target screening and due diligence to term sheet negotiation. Established deal frameworks and cultivated strategic partnerships with global biopharma companies.

Senior BD Manager

Yangtze River Pharmaceutical Group Co., Ltd.

2019-12 - 2022-8 · 2 yrs 9 mos

中国上海市

Led an 8-member innovation scouting and BD team responsible for early-stage asset identification, due diligence, and deal execution. In-licensing: Successfully sourced and evaluated multiple oncology assets, leading to successful partnerships for innovative oncology drugs Out-licensing: Advanced programs to Term Sheet stage, facilitating outbound licensing discussions with global partners Strategic leadership: Established team workflows for pipeline scouting, competitive intelligence, and cross-functional coordination Drove end-to-end BD execution from target identification to deal negotiation, contributing to pipeline expansion in oncology.

BD supervisor

Insud Pharma

2018-4 - 2019-12 · 1 yr 9 mos

上海市, 中国

Managed global pipeline in-licensing and portfolio strategy, leading cross-border BD transactions across multiple therapeutic areas. Pioneered the consumer health e-commerce business in China from ground zero — established online channels (Tmall, JD.com), built digital marketing capabilities, and drove revenue growth. Successfully bridged pharmaceutical innovation with consumer market expansion.

BD supervisor

妙通(上海)生物科技有限公司

2015-7 - 2018-4 · 2 yrs 10 mos

上海市, 中国

Responsible for global sourcing and execution of exclusive distribution agreements for the China market. Secured commercial rights for multiple international products across life sciences products. Also led government affairs and IP strategy — managed regulatory engagement, policy advocacy, and intellectual property portfolio to support market access and commercial growth.